Skip to main navigation Skip to search Skip to main content

Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations

  • Gee Chen Chang
  • , David Chi Leung Lam
  • , Chun Ming Tsai
  • , Yuh Min Chen
  • , Jin Yuan Shih
  • , Shyam Aggarwal
  • , Shuhang Wang
  • , Sang We Kim
  • , Young Chul Kim
  • , Ibrahim Wahid
  • , Rubi Li
  • , Darren Wan Teck Lim
  • , Virote Sriuranpong
  • , Raymond Tsz Tong Chan
  • , Robert M. Lorence
  • , Philippe Carriere
  • , Christina Raabe
  • , Agnieszka Cseh
  • , Keunchil Park
  • Veterans General Hospital-Taichung Taiwan
  • Chung Shan Medical University
  • The University of Hong Kong
  • Veterans General Hospital-Taipei
  • National Taiwan University
  • Sir Ganga Ram Hospital
  • Peking University
  • University of Ulsan
  • Chonnam National University
  • Beacon International Specialist Centre
  • St. Luke’s Medical Center
  • National Cancer Centre
  • Chulalongkorn University
  • Hong Kong Integrated Oncology Centre
  • Boehringer Ingelheim GmbH

Research output: Contribution to journal › Article › peer-review

3   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science